US EditionDouble CAR-T cell therapy proves successful for rare autoimmune disease
Summary by fau.eu
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Double CAR-T cell therapy proves successful for rare autoimmune disease
Researchers from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinikum Erlangen have succeeded in treating a patient with a particularly severe form of an autoimmune disease with two different types of CAR T-cells, one after another. The 45 year old woman who suffers from anti-synthetase syndrome has now been free of symptoms for over nine months, without having to take any… Source
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
